|
Oncology Competitive Intelligence Leaders
This year’s theme, “Crossing the Translational Divide: From Neurons to Novel Therapies,” closely mirrors our commitment to evaluating breakthrough scientific data and translating it into actionable competitive intelligence for oncology innovators. Our Ph.D. analysts look forward to tracking key clinical updates across gliomas, including emerging targeted therapies, cell therapies, and novel treatment combinations to keep […]
Medical Conference Coverage EHA: June 11-14, 2026 WCLC: September 12-15, 2026 ESMO: October 23-27, 2026 SNO: November 12-15, 2026 SABCS: December 8-11, 2026 ASH: December 12-15, 2026 ASCO GU: February 11-13, 2027 ELCC: March 17-20, 2027 SGO: March 19-22, 2027 AACR: April 2-7, 2027 ASCO: June 4-8, 2027 ICML: June 15-19, 2027 Antibody-Drug Conjugates (ADCs) […]
Excerpt from Custom Post Type Indication: Cell Therapies
Excerpt from Custom Post Type Indication: Gliomas
Director, Product Development